TLR7 and CD40 cooperate in IL-6 production via enhanced JNK and AP-1 activation

被引:54
作者
Bush, Tony J. Vanden [1 ]
Bishop, Gail A. [1 ,2 ]
机构
[1] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA
[2] Vet Assoc Med Ctr, Iowa City, IA USA
关键词
AP-1; B cells; CD40; JNK; TLR7;
D O I
10.1002/eji.200737602
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
During vaccination or infection, adaptive and innate immune receptors of B cells are engaged by microbial antigens/ligands. A better understanding of how innate and adaptive signaling pathways interact could enlighten B lymphocyte biology as well as aid immunotherapy strategies and vaccine design. To address this goal, we examined the effects of TLR stimulation on BCR and CD40-induced B cell activation. Synergistic production of IL-6 was observed in both human and mouse primary B cells stimulated through B cell antigen receptors, CD40 and TLR7, and these two receptors also cooperated independently of BCR signals. The enhanced IL-6 production was dependent upon the activity of c-Jun kinase (JNK) and cFos. Dual stimulation through CD40 and TLR7 markedly enhanced JNK activity. The increased level of active JNK in dual-stimulated cells was accompanied by an increase in the level of active AP-1 monomers cJun and cFos. The stimulation of B cells through both CD40 and TLR7 therefore enhanced the production of cytokines through increased JNK signaling and AP-1 activity. In addition, the dual stimulation increased cFos/AP-1 species in stimulated cells, effectively expanding the repertoire of AP-1 dimers as compared to singly stimulated B cells.
引用
收藏
页码:400 / 409
页数:10
相关论文
共 52 条
[1]   THE JUN PROTO-ONCOGENE IS POSITIVELY AUTOREGULATED BY ITS PRODUCT, JUN/AP-1 [J].
ANGEL, P ;
HATTORI, K ;
SMEAL, T ;
KARIN, M .
CELL, 1988, 55 (05) :875-885
[2]   New treatments for SLE: cell-depleting and anti-cytokine therapies [J].
Anolik, JH ;
Aringer, M .
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2005, 19 (05) :859-878
[3]   CD40-mediated transcriptional regulation of the IL-6 gene in B lymphocytes:: Involvement of NF-κB, AP-1, and C/EBP [J].
Baccam, M ;
Woo, SY ;
Vinson, C ;
Bishop, GA .
JOURNAL OF IMMUNOLOGY, 2003, 170 (06) :3099-3108
[4]  
Baccam M, 1999, EUR J IMMUNOL, V29, P3855, DOI 10.1002/(SICI)1521-4141(199912)29:12<3855::AID-IMMU3855>3.0.CO
[5]  
2-S
[6]   Promoter specificity and biological activity of tethered AP-1 dimers [J].
Bakiri, L ;
Matsuo, K ;
Wisniewska, M ;
Wagner, EF ;
Yaniv, M .
MOLECULAR AND CELLULAR BIOLOGY, 2002, 22 (13) :4952-4964
[7]   Toll-like receptor signaling pathways [J].
Barton, GM ;
Medzhitov, R .
SCIENCE, 2003, 300 (5625) :1524-1525
[8]   Plasmacytoid dendritic cells control TLR7 sensitivity of naive B cells via type IFN [J].
Bekeredjian-Ding, IB ;
Wagner, M ;
Hornung, V ;
Giese, T ;
Schnurr, M ;
Endres, S ;
Hartmann, G .
JOURNAL OF IMMUNOLOGY, 2005, 174 (07) :4043-4050
[9]   Daily or weekly therapy with resiquimod (R-848) reduces genital recurrences in herpes simplex virus-infected guinea pigs during and after treatment [J].
Bernstein, DI ;
Harrison, CJ ;
Tomai, MA ;
Miller, RL .
JOURNAL OF INFECTIOUS DISEASES, 2001, 183 (06) :844-849
[10]   Molecular mechanisms of B lymphocyte activation by the immune response modifier R-848 [J].
Bishop, GA ;
Hsing, Y ;
Hostager, BS ;
Julukar, SV ;
Ramirez, LM ;
Tomai, MA .
JOURNAL OF IMMUNOLOGY, 2000, 165 (10) :5552-5557